JPRN-UMIN000026525
Completed
未知
A phase II study of gemcitabine and nab-paclitaxel followed by chemoradiotherapy with S-1 in patients with locally advanced pancreatic cancer - A phase II study of gemcitabine and nab-paclitaxel followed by chemoradiotherapy with S-1 in patients with locally advanced pancreatic cancer
Chiba Cancer Center0 sites30 target enrollmentMarch 13, 2017
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Chiba Cancer Center
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\)Severe concurrent disease (2\)Interstitial pneumonia or severe pulmonary emphysema (3\)Clinically significant mental disorder (4\)Active concomitant malignancy (5\)Moderate or severe diarrhea, hemorrhagic colitis or peptic ulcer (6\)Infection requiring systemic treatment (7\)Fever of 38 degrees centigrade or higher (8\)Pregnant or lactating females (9\)Under treatment with systemic steroid or immunosuppressive agent (10\)Severe drug hypersensitivity (11\)Regular use of phenytoin, warfarin or frucitocin (12\)Gr2 or more peripheral sensory neuropathy (13\)Inappropriate for entry onto the study, as diagnosed by primary physician
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Phase I/II study of gemcitabine and nab-paclitaxel with radiation therapy in patients with pancreatic cancer.JPRN-UMIN000017751Department of Surgery, Keio University School of Medicine30
Active, not recruiting
Phase 1
Study of Nab-paclitaxel and Gemcitabine in Elderly Patients with Pancreatic CancerMetastatic pancreatic cancerMedDRA version: 17.1 Level: PT Classification code 10033610 Term: Pancreatic carcinoma metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2014-003596-27-ESAsociación de Oncología Médica del Hospital de Cruces (ASONMEC)80
Completed
Phase 2
Phase II study of Gemcitabine + nab-paclitaxel as first-line therapy for locally advanced pancreatic cancerlocally advanced unresectable pancreatic cancerJPRN-UMIN000016852Kurume university school of medicine24
Completed
Phase 2
Phase II study of gemcitabine plus nab-Pacletaxel as second-line therapy after FOLFIRINOX for advanced pancreatic canceradvanced pancreatic cancerJPRN-UMIN000016624Gifu University Hospital30
Completed
Not Applicable
Phase I/II study of Gemcitabine plus nab-paclitaxel and intraperitoneal paclitaxel for pancreas cancer with peritoneal metastasisThe patients with pancreatic cancer who have peritoneal metastasis diagnosed by staging laparoscopy or open laparotomy.JPRN-UMIN000018878Study group of pancreatic cancer with peritoneal metastasis48